These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36846471)

  • 21. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy.
    Sakurai K; Kawaguchi T; Kawai T; Ogino H; Hara M; Okita K; Yamawaki T; Shibamoto Y
    Neuroradiology; 2010 Sep; 52(9):809-14. PubMed ID: 19894040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
    Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T2*-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians.
    von Lewinski F; Werner C; Jörn T; Mohr A; Sixel-Döring F; Trenkwalder C
    J Neurol; 2007 Sep; 254(9):1184-8. PubMed ID: 17361340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.
    Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
    Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
    Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level.
    Baggio HC; Abos A; Segura B; Campabadal A; Uribe C; Giraldo DM; Perez-Soriano A; Muñoz E; Compta Y; Junque C; Marti MJ
    Neuroimage Clin; 2019; 22():101720. PubMed ID: 30785051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative susceptibility mapping depicts severe myelin deficit and iron deposition in a transgenic model of multiple system atrophy.
    Lambrecht V; Hanspach J; Hoffmann A; Seyler L; Mennecke A; Straub S; Marxreiter F; Bäuerle T; Laun FB; Winkler J
    Exp Neurol; 2020 Jul; 329():113314. PubMed ID: 32302677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
    PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy.
    Beliveau V; Krismer F; Skalla E; Schocke MM; Gizewski ER; Wenning GK; Poewe W; Seppi K; Scherfler C
    Parkinsonism Relat Disord; 2021 Apr; 85():30-36. PubMed ID: 33713904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The "Black Straight-Line Sign" in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy.
    Zheng Y; Wang X; Zhao H; Jiang Y; Zhu Y; Chen J; Sun W; Wang Z; Sun Y
    Front Neurol; 2022; 13():890168. PubMed ID: 35665040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphology and signal changes of the lentiform nucleus based on susceptibility weighted imaging in parkinsonism-predominant multiple system atrophy.
    Ren Q; Meng X; Zhang B; Zhang J; Shuai X; Nan X; Zhao C
    Parkinsonism Relat Disord; 2020 Dec; 81():194-199. PubMed ID: 33189038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Putaminal hypointensity in the parkinsonian variant of multiple system atrophy: simple visual assessment using susceptibility-weighted imaging.
    Lee JH; Baik SK
    J Mov Disord; 2011 Oct; 4(2):60-3. PubMed ID: 24868396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.
    Péran P; Barbagallo G; Nemmi F; Sierra M; Galitzky M; Traon AP; Payoux P; Meissner WG; Rascol O
    Mov Disord; 2018 Apr; 33(4):600-608. PubMed ID: 29473662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes.
    Stern MB; Braffman BH; Skolnick BE; Hurtig HI; Grossman RI
    Neurology; 1989 Nov; 39(11):1524-6. PubMed ID: 2812334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging.
    Nair SR; Tan LK; Mohd Ramli N; Lim SY; Rahmat K; Mohd Nor H
    Eur Radiol; 2013 Jun; 23(6):1459-66. PubMed ID: 23300042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.